Developmental dysplasia of the hip
Conditions
Interventions
Control Group:Sufentanil Citrate injection PCIA
Experimental Group:Hydromorphone hydrochloride injection PCIA
Sponsors
Department of Aensthesiology and Surgery, The Second Hospital l of Lanzhou University
Eligibility
Sex/Gender
All
Age
2 Years to 5 Years
Inclusion criteria
Inclusion criteria: 1. ASA I or II; 2. aged 2-5 years; 3. Developmental dysplasia of the hip repair surgery under general anesthesia; 4. Participate in the trial after families consent; 5. Accord with conditions of general anesthesia.
Exclusion criteria
Exclusion criteria: 1. Serious congenital heart disease untreated; 2. Difficult airway; 3. Contraindications or allergy to opioid drugs; 4. Poor collaboration of paents; 5. Researchers think that there are inappropriate factors for selected conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resting and Moving FLACC scores;The time of FLACC reduced to less than 4;Additional numbers of blous; | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction of the anagesia;The observers assessment of sedation scale;Post-operative hospital stay;Behavior changes of postoperation; | — |
Countries
China
Contacts
Public ContactSHI Yisa
Outcome results
None listed